Dijkman Marieke A, de Vries Irma, Mulder-Spijkerboer Henneke, Meulenbelt Jan
Universitair Medisch Centrum Utrecht, Nationaal Vergiftigingen Informatie Centrum (NVIC), Utrecht, the Netherlands.
Ned Tijdschr Geneeskd. 2012;156(42):A4983.
Since 2011, cobalt and chromium blood levels are measured in patients with a metal-on-metal hip implant (MoM prosthesis). In this article we discuss the health risks that are related to chronically elevated blood cobalt concentrations induced by abnormal wear and corrosion of the MoM prosthesis. Only a few patients who have systemic symptoms of poisoning, besides local symptoms around the failing MoM prosthesis, have been described in the literature. Toxic blood cobalt concentrations may be accompanied by hypothyroidism, polyneuropathy, impairment of cranial nerves II and VIII and cardiomyopathy. Treatment consists of removal of the prosthesis. In patients with a normal kidney function, the cobalt blood levels rapidly decrease and symptoms of cobalt intoxication subside. Chelation therapy should be restricted to those patients who are unable to undergo removal of the prosthesis immediately due to their medical condition. This can for example be because of a severe cobalt-induced cardiomyopathy.
自2011年起,对接受金属对金属髋关节植入物(金属对金属假体)的患者进行血液钴和铬水平检测。在本文中,我们讨论了因金属对金属假体异常磨损和腐蚀导致血液钴浓度长期升高所带来的健康风险。文献中仅描述了少数除失败的金属对金属假体周围局部症状外还出现全身中毒症状的患者。血液中钴浓度达到中毒水平时可能伴有甲状腺功能减退、多发性神经病变、II和VIII颅神经损伤以及心肌病。治疗方法为取出假体。对于肾功能正常的患者,血液钴水平会迅速下降,钴中毒症状也会消退。螯合疗法应仅限于那些因病情无法立即取出假体的患者。例如,这可能是由于严重的钴诱导性心肌病。